Look for Pharma Talent with Fleming Europe
News Feb 27, 2012
Staying competitive in the pharmaceutical industry requires the ability to bridge gaps between multi-disciplinary areas such as science, business, law and public relations. The most successful pharma and biotech companies know that behind the success is a pool of talented personnel that are able to think outside the box and adapt to an ever-evolving environment.
Fleming Europe has organized the Talent Forward 2012, its 7th edition of the successful Pharma HR series. The event will take place in the comfort of the Hotel Rey Juan Carlos I, in Barcelona on 3 – 4 May 2012.
The Masterclass session, “Aligning organizational coaching to talent management strategy,” will be the center of attention. Facilitated by Dr. Paul Turner, Honorary research fellow from Birmingham city university, UK, will concentrate on talent challenges in the pharma industry, various dimensions of talent management, and coaching & relationship management capability.
The Talent forward 2012 survey, currently available online, will conclude the afternoon session. The evaluation and results advices will be presented and discussed.
The 2-day conference will be rich in topics and will cover all the stages in the pharma talent life-cycle – innovative pharma HR talent acquisition, finding talent for special positions, developments in talent mapping, examples of the most effective talent development programs, clever talent retention and reengagement and the influence of popular social media.
Panel discussions enabling the interaction with prominent speakers from Pfizer, Sanofi Aventis, GlaxoSmithKline, Eli Lilly, Abbott, Amgen, Sandoz, Nycomed, Merck, Shire, etc. are scheduled throughout the conference.
The pharmaceutical industry of developed economies is already saturated with a dedicated workforce. In emerging markets pharma companies have to fight for qualified personnel. How to “capture & hire” is only the first step to take. How to retain such talent is the vital question these companies need to answer.
New Automated Screening Method for Identifying Drug CandidatesNews
Scientists at DESY have developed a new method that enables automated and fast screening of promising drug candidates.READ MORE
Metabolomic Profiling Identifies Taurine as New MS TherapeuticNews
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.READ MORE
Immune Response Restored in Patients with Melanoma Thanks to New CompoundNews
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.READ MORE